Flyer for symposium: https://ctrlepiedit.sciencesconf.org/
Very excited to announce the FIRST symposium on epigenome editing! These tools are becoming widely used in mol bio, ag & therapy. It's time to bring leaders together to discuss this rapidly growing and exciting field. And why not in Paris! Please register & share! (1/2) ctrlepiedit.sciencesconf.org
09.03.2026 13:15
π 52
π 31
π¬ 3
π 5
Up to $1.4 billion in medical research remains unused under government cap
Researchers say securing funding has become increasingly tough, with many left with no choice but to spend a disproportionate amount of time applying for grants.
More than 60% of Australian medical researchers left active research roles between 2019 & 2024 because they could not make ends meet - while my costings from the PBO suggest the govt could more than double annual spending from the MRFF without any effect on its base level of funding.
09.03.2026 04:45
π 130
π 47
π¬ 5
π 3
π¨ New paper from our lab just published in Natureπ¨
www.nature.com/articles/s41...
Discover how π± tumour formation is shaped by tissue context from the very beginning. Cancer is not driven by genetics alone
β¨Fantastic team led by Greta Skrupskelyte, Eduardo Rojo, @hariajith.bsky.social
04.03.2026 16:08
π 95
π 37
π¬ 9
π 7
Try spinning down your antibodies before using. You can also add some tween to your wash buffers
03.03.2026 19:55
π 2
π 0
π¬ 1
π 0
Frustrated I canβt be in person at #KSEpigenetics26. Unfortunately I couldnβt travel to Geneva from Australia due to the conflict in the Middle East.
Hoping everyone has a great conference and Iβll be able to join in person next time!
03.03.2026 09:05
π 4
π 0
π¬ 0
π 0
2026 Winner of the Lorne Genome Julian Wells Medal: Christine Wells (no relation!) @stemcellsystems.bsky.social congratulations, well deserved!!
18.02.2026 00:18
π 13
π 5
π¬ 1
π 0
Tongtong Wang presenting at Lorne Genome 2026
Tongtong Wang @petermaccc.bsky.social kicking off the computational Biology parallel session introducing EmbryoRadar, a machine learning model to identify developmental programs reactivated in cancer.
16.02.2026 00:32
π 2
π 1
π¬ 0
π 0
So exciting to see ASSCR partner with @isscr.org to support Australasian student and ECR researchers to attend the ISSCR Annual meeting in Montreal!! This Joint Travel Award, the first of its kind, will enable more interactions with the international community for our EMCR members!!
#stemcells
09.02.2026 06:39
π 3
π 2
π¬ 0
π 0
New ISSCR-ASSCR joint travel awards to support Australian students and EMCRs to attend @isscr.org annual meeting in Montreal
07.02.2026 23:38
π 2
π 1
π¬ 0
π 0
Our new preprint on SMCHD1! Weβve shown SMCHD1βs ATPase activity is critical for function in vivo, and excitingly a new DNA binding domain neighbouring the ATPase domain activates the enzymatic function, which is important for normal chromatin binding.
urldefense.com/v3/__https:/...
06.02.2026 07:56
π 33
π 14
π¬ 1
π 1
Lovely lab hike in Werribee Gorge to celebrate the EckMasLabβs 5th birthday π
05.02.2026 21:30
π 12
π 1
π¬ 0
π 1
A Triumvirate of Transformation: Oncogene, Ontogeny, and Plasticity
Summary:. Cancer cells display extensive heterogeneity that influences therapy response and clinical outcome, yet the underlying mechanisms remain incompletely understood. Recent studies reveal that t...
New Spotlight in @aacrjournals.bsky.social
#Oncogene Γ #Ontogeny Γ #Plasticity shape leukemia biology & therapy response.
Two complementary studies show: mutations alone donβt explain disease behaviorβdevelopmental state and cellular plasticity matter.
aacrjournals.org/bloodcancerd...
π©Έπ§¬
EpiSci
04.02.2026 18:28
π 7
π 4
π¬ 1
π 0
Institut Pasteur (@pasteur.fr) is recruiting new young PIs to open new groups in the Institute. Deadline is February 9th! Don't miss the opportunity!
27.01.2026 18:56
π 34
π 49
π¬ 0
π 0
SS18::SSX activates Polycomb target genes without BAF β
Instead, transcription relies on EP300 via the SS18 QPGY domain
www.biorxiv.org/content/10.6...
β‘οΈ Coactivator targeting emerges as a new therapeutic strategy in synovial sarcoma π―
Team work from @banitolab.bsky.social and @uoe-igc.bsky.social
28.01.2026 10:20
π 22
π 16
π¬ 3
π 0
SS18-SSX co-opts P300 to sustain oncogenic transcription independent of SWI/SNF activity
Synovial sarcoma is driven by the SS18-SSX fusion oncoprotein, which has been assumed to promote tumorigenesis through its incorporation into the SWI/SNF chromatin remodeling complexes. Accordingly, therapeutic efforts have focused on targeting SS18-SSX containing SWI/SNF assemblies, yet these approaches have produced limited clinical benefit. Here, we demonstrate that SS18-SSX sustains oncogenic transcription independent of SWI/SNF activity. Despite efficient degradation and dismantling of SWI/SNF complexes, fusion occupancy at target loci and associated gene expression programs remain largely intact. Instead, we identify the acetyltransferase P300 as an essential co-factor supporting SS18-SSX chromatin binding and transcriptional activation. Targeting P300 displaces the fusion from chromatin, suppresses its transcriptional output, compromising synovial sarcoma viability. Notably, dual PROTAC mediated degradation of P300 and SWI/SNF produces strong synergistic effects, broadly disrupting SS18-SSX localization and function. These findings redefine the mechanistic basis of synovial sarcoma and reveal a mechanistically anchored therapeutic strategy for targeting its core oncogenic driver. ### Competing Interest Statement C.R.V. has been a consultant for Flare Therapeutics, Roivant Sciences and C4 Therapeutics; has served on the advisory boards of KSQ Therapeutics, Syros Pharmaceuticals and Treeline Biosciences; has received research funding from Boehringer Ingelheim and Treeline Biosciences; and owns stock in Treeline Biosciences. S.A.A. has been a consultant and/or shareholder for Neomorph, Imago Biosciences, Hyku Therapeutics, C4 Therapeutics, Accent Therapeutics and Nimbus Therapeutics; and has received research support from Janssen and Syndax. N.O.C. is a co-founder, shareholder and management consultant for PhenoTherapeutics Ltd; and a shareholder in Amplia Therapeutics Ltd All other authors declare no financial interests UKRI, EP/X039633/1 Worldwide Cancer Research, https://ror.org/031tfbz57, 21-0271 Science Foundation Ireland, https://ror.org/0271asj38, 18/SIRG/5573
Synovial sarcoma is driven almost exclusively by a single oncofusion β SS18-SSX
For years, the assumptions on disease mechanisms were simple:
β‘οΈ SS18-SSX works by hijacking SWI/SNF chromatin remodeling activity
Our new study shows that assumption was wrong π§΅π
www.biorxiv.org/content/10.6...
28.01.2026 09:54
π 30
π 12
π¬ 2
π 3
#FragileNuclesome is back tomorrow! Join us to hear about exciting talks from:
- @au-ho-yu.bsky.social in @robklose.bsky.social's group about transcriptional control by SET1/MLL complexes
- @gcloner.bsky.social at @epicypher.bsky.social about the histone PTM landscape of the immune system
27.01.2026 18:24
π 9
π 5
π¬ 0
π 0
Great to catch up with alumni @nchoy.bsky.social who stopped by to visit the lab. So great to hear about your internship adventures with @robertife.bsky.social and see you doing so well!
23.01.2026 07:00
π 8
π 1
π¬ 0
π 0
Medical Research Matters
Right now, the Government is starving medical research of full funding, even as it claims that science and research are national priorities. If our leaders truly value science as much as they say, then they must back their words with actionβand fund it properly.
Join the campaign!
23.01.2026 05:23
π 99
π 44
π¬ 4
π 6
Humbled to have recieved NHMRC funding to understand molecular underpinnings of breast cancer plasticity.
Sadly, the bleak 8% success means many deserving applications went unfunded. Australia is missing out on scientific discoveries and all the direct and indirect benefits this brings our society.
14.01.2026 07:46
π 10
π 0
π¬ 1
π 0
π ASSCR Call for Reviewers (2026)
PhD-qualified members are invited to join the Abstract & Awards reviewer panel.
ποΈ Commitment AugβNov | ~20β30 abstracts
π
Apply by 12 Jan 2026
π docs.google.com/forms/d/e/1F...
#ASSCR #StemCells
06.01.2026 03:00
π 0
π 1
π¬ 0
π 0
Most researchers miss out on innovation grants while medical fund sits on $25b
Nine in 10 Australian researchers had their βideas grantβ applications rejected last year, even as Australiaβs medical investment fund sits on $5 billion more than it was designed to hold.
The government canβt claim that medical research is a priority while failing to treat it as one. Nine in 10 leading researchers in Australia are missing out on government support for worldβclass proposals, leaving exceptional talent uncertain about their future.
03.01.2026 23:32
π 108
π 48
π¬ 2
π 2
Just quit
Quitting projects in science is hard, but we should be doing a lot more of it.
Blog post: Just quit
Quitting projects in science is hard, but we should be doing a lot more of it.
open.substack.com/pub/arjunraj...
30.12.2025 15:02
π 186
π 50
π¬ 13
π 14
Celebrating a wonderful end to 2025! Wishing everyone a happy festive season and happy new year
16.12.2025 09:35
π 15
π 1
π¬ 0
π 0
Australiaβs medical and scientific research sectors save lives and are vital to our economy. The government has to step up and lean in to their potential.
Itβs small-minded and short-sighted to force them to wither on the vine, when we have money put aside for this purpose in the Future Fund.
07.12.2025 22:25
π 48
π 20
π¬ 2
π 0
Half the Funding. Half the Future. - AAMRI
The Medical Research Future Fund (MRFF) was designed to deliver $1 billion each year in new, lifesaving funding for medical research. We know through financial modelling that the full amount can be re...
The Medical Research Future Fund (MRFF) funds medical research in Australia. Only half the funds have been released. If you're an Australian and able to vote please use the form below to email your local MP to release the full amount of the MRFF
aamri.org.au/mrff/
16.11.2025 21:14
π 7
π 7
π¬ 0
π 0
Great first day of stem cell science on the beach at #ASSCR2025! Here is our @asscr.bsky.social president opening the conference. Highlights include keynote from @josh-brickman.bsky.social and presentation of @ausstemcell.bsky.social 2025 Metcalf awards. Congratulations to the worthy recipients!
10.11.2025 08:54
π 5
π 2
π¬ 0
π 0
Speakers β Lorne Genome
No description found
Last chance! Early bird rates and oral presentation abstract submissions for Lorne Genome ππ§π ππ¨π―ππ¦πππ« πππ‘, ππππ - only one week away: https://www.lornegenome.org/registrations
We have a fantastic lineup of national and international speakers: https://www.lornegenome.org/speakers. Join us!
30.10.2025 21:30
π 6
π 6
π¬ 0
π 0